Skip to Content
Velkommen til Revmatologi

Revmatologi • Nye kliniske perspektiver, studiedata og behandlings-alternativer

The COVID-19 pandemic: How do we produce firm evidence for the treatment of a novel disease?

  • / Anne Kathrine Lorentzen / Carsten Sauer Mikkelsen / Luit Penninga
Back to top